Seres Therapeutics
MCRB
#10502
Rank
A$56.41 M
Marketcap
A$5.62
Share price
-2.44%
Change (1 day)
-79.38%
Change (1 year)

Market capitalization of Seres Therapeutics (MCRB)

Market cap: A$56.41 Million

As of September 2026 Seres Therapeutics has a market cap of A$56.41 Million. This makes Seres Therapeutics the world's 10502th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Seres Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026A$56.41 M-71.49%
2025A$0.19 B-14.4%
2024A$0.23 B-12.98%
2023A$0.26 B-74.09%
2022A$1.02 B-2.89%
2021A$1.05 B-63.77%
2020A$2.91 B743.12%
2019A$0.34 B31.59%
2018A$0.26 B-50.11%
2017A$0.52 B-5.02%
2016A$0.55 B-70.56%
2015A$1.88 B

End of Day market cap according to different sources

On Sep 17th, 2026 the market cap of Seres Therapeutics was reported to be:

A$57.83 Million
by Nasdaq info icon info icon
A$57.83 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
A$2.58 B 4,474.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
A$2.77 B 4,813.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.35 B 27,107.16%๐Ÿ‡บ๐Ÿ‡ธ USA